Production of urokinase-type plasminogen activator (u-PA) and plasminogen activator inhibitor-1 (PAI-1) in human brain tumors

Insulin-dependent and-independent expressions of plasminogen-activator inhibitor (PAI-1) in obesity, especially in visceral type obesity

Inhibitory effect of a synthetic prostacyclin analogue, beraprost, on urokinase-type plasminogen activator gene expression in RC-K8 human lymphoma cells